(Q72354142)

English

Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients

scientific article published on 01 January 1995

Statements

Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit